Pediatricians’ perceptions, practices, and barriers regarding COVID-19 vaccine for children: A cross-sectional survey in Ontario, Canada-Reference-Cited by-同舟云学术

Pediatricians’ perceptions, practices, and barriers regarding COVID-19 vaccine for children: A cross-sectional survey in Ontario, Canada

Published:2023-05 Issue:19 Volume:41 Page:3058-3065
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Ali Yamna^ORCID,Piche-Renaud Pierre-Philippe^ORCID,Karimi-Shahrbabak Elahe,Farrar Daniel S.^ORCID,Fadaleh Sarah Abu,Burey Sharon,Morris Shaun K.^ORCID

Funder

Public Health Agency of Canada

Natural Sciences and Engineering Research Council of Canada

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference24 articles.

1. Health Canada. Health Canada authorizes use of the Pfizer-BioNTech COVID-19 vaccine in children 12 to 15 years of age, https://www.canada.ca/en/health-canada/news/2021/05/health-canada-authorizes-use-of-the-pfizer-biontech-covid-19-vaccine-in-children-12-to-15-years-of-age/; 2021 [accessed 10 November 2022].

2. Health Canada. Health Canada authorizes use of Comirnaty (the Pfizer-BioNTech COVID-19 vaccine) in children 5 to 11 years of age, https://www.canada.ca/en/health-canada/news/2021/11/health-canada-authorizes-use-of-comirnaty-the-pfizer-biontech-covid-19-vaccine-in-children-5-to-11-years-of-age/; 2021 [accessed 10 November 2022].

3. Health Canada. Health Canada authorizes use of Moderna COVID-19 vaccine in children 6 months to 5 years of age, https://www.canada.ca/en/health-canada/news/2022/07/health-canada-authorizes-use-of-moderna-covid-19-vaccine-in-children-6-months-to-5-years-of-age/; 2022 [accessed 10 November 2022].

4. Government of Canada. COVID-19 vaccination in Canada, https://health-infobase.canada.ca/covid-19/vaccination-coverage/; 2022 [accessed 3 January 2022].

5. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12–18 years — United States, July–December 2021;Zambrano;Morb Mortal Wkly Rep,2022